Corbus Pharmaceuticals Price Target Announced at $35.00/Share by Piper Sandler

Dow JonesDec 2 05:57 ET · Ratings

Corbus Pharmaceuticals Analyst Ratings

BenzingaDec 2 05:46 ET · Ratings

Piper Sandler Initiates Corbus Pharmaceuticals(CRBP.US) With Buy Rating, Announces Target Price $35

Moomoo NewsDec 2 05:34 ET · Ratings

Express News | Corbus Pharmaceuticals Holdings Inc : Piper Sandler Initiates Coverage With Overweight Rating; Price Target $35

ReutersDec 2 04:15 ET

Corbus Pharmaceuticals Holdings, Inc. (CRBP): An Oversold Healthcare Stock to Invest In Now

Yahoo FinanceNov 26 06:54 ET

Corbus Pharmaceuticals to Present at the 7th Annual Evercore HealthCONx Conference

GlobeNewswireNov 21 08:00 ET